Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Fleshner

Showing results (71-80 of 266) with videos related to

Pageof 27
Sort By:
The Canadian Journal of Urology|July 5, 2006
Surgical wait times for patients with urological cancers: a survey of Canadian surgeonsNeil Fleshner, George Dranitsaris, Antonio Finelli, et al.
The Journal of Urology|July 24, 2018
Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate CancerRoman Bass, Neil Fleshner, Antonio Finelli, et al.
The Canadian Journal of Urology|November 9, 2005
Development of prostate cancer quality indicators: a modified Delphi approachAnna R Gagliardi, Neil Fleshner, Bernard Langer, et al.
Urology|December 29, 2009
Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancerAlfonso Gómez-Iturriaga Piña, Juanita Crook, Jette Borg, et al.
The Prostate|July 13, 2016
Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer CellsNicole M A White-Al Habeeb, Julia Garcia, Neil Fleshner, et al.
The Canadian Journal of Urology|March 7, 2006
Treatment of the inguinal regions in penile cancer: a review of the literature and treatment proposalDaniel Taussky, Juanita Crook, Abdullah Al Ghamdi, et al.
Glycobiology|August 3, 2013
Cholesterol masks membrane glycosphingolipid tumor-associated antigens to reduce their immunodetection in human cancer biopsiesAnton Novak, Beth Binnington, Bo Ngan, et al.
Proteomics. Clinical Applications|August 5, 2015
Multidimensional protein identification technology analysis highlights mitoxantrone-induced expression modulations in the primary prostate cancer cell proteomeJuliane Symes, Andreas Evangelou, Alex Ignatchenko, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 28, 2015
Time from first detectable PSA following radical prostatectomy to biochemical recurrence: A competing risk analysisLeonora de Boo, Melania Pintilie, Paul Yip, et al.
Clinical Biochemistry|November 5, 2002
Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observationPeter S Bunting, Gerrit DeBoer, Richard Choo, et al.
Pageof 27

Showing results (71-80 of 266) with videos related to

Sort By:
Pageof 27
The Canadian Journal of Urology|July 5, 2006
Surgical wait times for patients with urological cancers: a survey of Canadian surgeonsNeil Fleshner, George Dranitsaris, Antonio Finelli, et al.
The Journal of Urology|July 24, 2018
Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate CancerRoman Bass, Neil Fleshner, Antonio Finelli, et al.
The Canadian Journal of Urology|November 9, 2005
Development of prostate cancer quality indicators: a modified Delphi approachAnna R Gagliardi, Neil Fleshner, Bernard Langer, et al.
Urology|December 29, 2009
Median 5 year follow-up of 125iodine brachytherapy as monotherapy in men aged<or=55 years with favorable prostate cancerAlfonso Gómez-Iturriaga Piña, Juanita Crook, Jette Borg, et al.
The Prostate|July 13, 2016
Metformin Elicits Antitumor Effects and Downregulates the Histone Methyltransferase Multiple Myeloma SET Domain (MMSET) in Prostate Cancer CellsNicole M A White-Al Habeeb, Julia Garcia, Neil Fleshner, et al.
The Canadian Journal of Urology|March 7, 2006
Treatment of the inguinal regions in penile cancer: a review of the literature and treatment proposalDaniel Taussky, Juanita Crook, Abdullah Al Ghamdi, et al.
Glycobiology|August 3, 2013
Cholesterol masks membrane glycosphingolipid tumor-associated antigens to reduce their immunodetection in human cancer biopsiesAnton Novak, Beth Binnington, Bo Ngan, et al.
Proteomics. Clinical Applications|August 5, 2015
Multidimensional protein identification technology analysis highlights mitoxantrone-induced expression modulations in the primary prostate cancer cell proteomeJuliane Symes, Andreas Evangelou, Alex Ignatchenko, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 28, 2015
Time from first detectable PSA following radical prostatectomy to biochemical recurrence: A competing risk analysisLeonora de Boo, Melania Pintilie, Paul Yip, et al.
Clinical Biochemistry|November 5, 2002
Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observationPeter S Bunting, Gerrit DeBoer, Richard Choo, et al.
Pageof 27